Skip to main content

Peer Review reports

From: Genetic variations in anti-diabetic drug targets and COPD risk: evidence from mendelian randomization

Original Submission
23 Aug 2023 Submitted Original manuscript
27 Dec 2023 Reviewed Reviewer Report - Hesham A. Abdelhalim
29 Dec 2023 Reviewed Reviewer Report
14 Jan 2024 Author responded Author comments - Jinfu Xu
21 Jan 2024 Author responded Author comments - Jinfu Xu
Resubmission - Version 2
14 Jan 2024 Submitted Manuscript version 2
25 Jan 2024 Author responded Author comments - Jinfu Xu
Resubmission - Version 3
25 Jan 2024 Submitted Manuscript version 3
29 Jan 2024 Author responded Author comments - Jinfu Xu
Resubmission - Version 4
29 Jan 2024 Submitted Manuscript version 4
2 Feb 2024 Author responded Author comments - Jinfu Xu
Resubmission - Version 5
2 Feb 2024 Submitted Manuscript version 5
9 Feb 2024 Reviewed Reviewer Report - Hesham A. Abdelhalim
22 Feb 2024 Reviewed Reviewer Report
Resubmission - Version 6
Submitted Manuscript version 6
Publishing
9 Mar 2024 Editorially accepted
15 May 2024 Article published 10.1186/s12890-024-02959-1

You can find further information about peer review here.

Back to article page